Latest Investment News

Rhythm Biosciences has inked a non-exclusive distribution agreement with 4Cyte Pathology to integrate its ColoSTAT® colorectal cancer blood test into a vast pathology network across eastern Australia, aiming to boost adoption and accessibility.

BHP Group Limited reported a robust half-year to December 2025, with copper overtaking iron ore as the top earnings contributor and a detailed technical assessment released for its promising Vicuña copper-gold project.

SEEK Limited reported robust H1 FY2026 results, powered by AI-driven product innovation and pricing, delivering strong revenue and profit growth alongside a record interim dividend. However, a significant impairment on its Zhaopin investment weighed on reported earnings.

SEEK Limited has reported a robust first half for FY2026, driven by AI-enhanced products and strategic pricing, resulting in double-digit revenue growth and a record interim dividend.

SEEK Limited posted strong half-year revenue growth and record dividends, but a hefty impairment charge on its Chinese associate Zhaopin led to a significant net loss. The company’s strategic platform unification and Sidekicker reacquisition underpin operational momentum despite macroeconomic headwinds.

Sims Limited reported a 3.7% rise in half-year sales revenue to A$3.78 billion, propelled by strong non-ferrous prices and robust growth in its Lifecycle Services division. Underlying EBIT soared 65.9%, reflecting strategic acquisitions and operational efficiencies despite challenging ferrous markets.

Sims Limited reported a robust fiscal 2026 half-year underlying profit, boosted by strong performances in its Lifecycle Services and North American metal operations. Despite statutory losses from derivative impacts, the company declared a healthy interim dividend and outlined strategic investments for future growth.

Baby Bunting has reported record half-year sales and margin growth for 1H FY26, underpinned by its Store of the Future refurbishments and strategic expansions. The company maintains its full-year profit guidance while unveiling a new exclusive partnership with premium brand Stokke.

Baby Bunting has reported a robust first half FY26 performance, driven by strong sales growth and a record gross margin, while maintaining its full-year profit guidance amid ongoing store refurbishments.

Baby Bunting reported a 6.7% rise in revenue to $271.4 million for H1 2026, while statutory net profit after tax fell 52.5%. Adjusted earnings paint a steadier picture with a 4.1% increase in pro forma NPAT.

Deterra Royalties Limited has announced a fully franked ordinary dividend of AUD 0.124 per share for the half-year ending December 2025, accompanied by a Dividend Reinvestment Plan offering shareholders a no-discount option to reinvest.

Deterra Royalties Limited has reported a record half-year net profit after tax of A$87.2 million, driven by strong revenue growth from its core Mining Area C royalty and successful divestment of non-core assets. The company also declared a higher fully franked interim dividend and advanced its Thacker Pass lithium project in Nevada.